Literature DB >> 22974759

A critical role of N-myc and STAT interactor (Nmi) in foot-and-mouth disease virus (FMDV) 2C-induced apoptosis.

Jianchang Wang1, Yongqiang Wang, Jue Liu, Lin Ding, Quanhong Zhang, Xiaoqi Li, Hong Cao, Jun Tang, Shijun J Zheng.   

Abstract

Foot-and-mouth disease virus (FMDV) 2C, is one of the most highly-conserved viral proteins among the serotypes of FMDV. However, its effect on host cells is not very clear. Using yeast two-hybrid system and immunoprecipitation approaches, we found that FMDV 2C interacted with the N-myc and STAT interactor (Nmi) protein. When expressed in cells, FMDV 2C is mainly associated with endoplasmic reticulum in the forms of speckles. In the absence of FMDV 2C, Nmi was distributed diffusely in the cytoplasm. However, upon FMDV 2C overexpression Nmi was recruited into FMDV 2C containing speckles where both proteins are co-localized. In addition, FMDV 2C induced apoptosis in BHK-21 cells, which was markedly inhibited by Nmi knockdown, suggesting that Nmi may play a critical role in FMDV 2C-induced apoptosis. These findings may help to further understand the molecular mechanism of pathogenesis of FMDV infection.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974759     DOI: 10.1016/j.virusres.2012.08.018

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  16 in total

1.  Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.

Authors:  Huisheng Liu; Zixiang Zhu; Qiao Xue; Fan Yang; Weijun Cao; Keshan Zhang; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

2.  Genetic variants in N-myc (and STAT) interactor and susceptibility to glioma in a Chinese Han population.

Authors:  Delong Meng; Xiaoying Li; Shuo Zhang; Yingjie Zhao; Xiao Song; Yuanyuan Chen; Shiming Wang; Ying Mao; Hongyan Chen; Daru Lu
Journal:  Tumour Biol       Date:  2014-11-12

3.  N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm.

Authors:  Xiaomei Hu; Wei Yang; Ruikang Liu; Yunqi Geng; Wentao Qiao; Juan Tan
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

4.  Foot-and-Mouth Disease Virus Inhibits RIP2 Protein Expression to Promote Viral Replication.

Authors:  Huisheng Liu; Qiao Xue; Zixiang Zhu; Fan Yang; Weijun Cao; Xiangtao Liu; Haixue Zheng
Journal:  Virol Sin       Date:  2021-01-05       Impact factor: 4.327

5.  High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.

Authors:  Delong Meng; Yuanyuan Chen; Dapeng Yun; Yingjie Zhao; Jingkun Wang; Tao Xu; Xiaoying Li; Yuqi Wang; Li Yuan; Ruochuan Sun; Xiao Song; Cong Huai; Lingna Hu; Song Yang; Taishan Min; Juxiang Chen; Hongyan Chen; Daru Lu
Journal:  Oncotarget       Date:  2015-03-10

Review 6.  Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination.

Authors:  Hawley C Pruitt; Daniel J Devine; Rajeev S Samant
Journal:  Int J Cancer       Date:  2016-03-11       Impact factor: 7.396

7.  Adaption of FMDV Asia-1 to Suspension Culture: Cell Resistance Is Overcome by Virus Capsid Alterations.

Authors:  Veronika Dill; Bernd Hoffmann; Aline Zimmer; Martin Beer; Michael Eschbaumer
Journal:  Viruses       Date:  2017-08-18       Impact factor: 5.048

8.  A human torque teno virus encodes a microRNA that inhibits interferon signaling.

Authors:  Rodney P Kincaid; James M Burke; Jennifer C Cox; Ethel-Michele de Villiers; Christopher S Sullivan
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

Review 9.  Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements.

Authors:  Yuan Gao; Shi-Qi Sun; Hui-Chen Guo
Journal:  Virol J       Date:  2016-06-22       Impact factor: 4.099

10.  N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells.

Authors:  Juan C Corredor; Nicole Redding; Karen Bloté; Stephen M Robbins; Donna L Senger; John C Bell; Paul Beaudry
Journal:  Mol Ther Oncolytics       Date:  2016-03-16       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.